Navidea Biopharmaceuticals, Inc.
(NYSE Amex Equities : NAVB)

... ...
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson 2.62%170.340.7%$1277.19m
PFEPfizer Inc. 0.47%37.460.9%$1199.30m
LLYEli Lilly & Co. -0.38%211.551.1%$1013.08m
ABBVAbbVie, Inc. -0.98%109.421.9%$753.47m
AZNAstraZeneca Plc 0.76%54.421.2%$709.69m
BMYBristol-Myers Squibb Co. -0.08%64.781.0%$702.21m
MRKMerck & Co., Inc. -1.00%80.340.7%$700.90m
ARCTArcturus Therapeutics Holdings, Inc. -4.95%66.000.0%$226.28m
VTRSViatris, Inc. -0.29%17.180.0%$197.58m
RPRXRoyalty Pharma Plc 1.96%52.510.2%$184.39m
NVSNovartis AG -2.90%95.610.2%$184.39m
GRTSGritstone Oncology, Inc. -11.61%21.090.0%$166.85m
GSKGlaxoSmithKline Plc 0.84%39.250.2%$163.42m
SNYSanofi -1.31%48.980.2%$137.12m
TAKTakeda Pharmaceutical Co., Ltd. -0.14%18.350.0%$81.16m

Company Profile

Navidea Biopharmaceuticals, Inc. engages in the development and commercialization of precision immunodiagnostic agents and immunotherapeutic. It operates through the following segments: Diagnostics, Therapeutics, and Corporate. The company was founded in 1983 and is headquartered in Dublin, OH.